Literature DB >> 22082548

Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.

Akio Ogura1, Katsumi Hayakawa, Syouko Yoshida, Fumie Maeda, Fumito Saeki, Ai Syukutani.   

Abstract

BACKGROUND: The Breast Imaging Reporting and Data System (BI-RADS) of the American College of Radiology recommends careful examination of the region of interest (ROI) in areas that seem to show a washout pattern on time-intensity curve (TIC). However, it is difficult to identify malignancies because many benign lesions also show enhancement, and these include cysts, hemorrhage, fibrosis, and necrosis in the mass.
PURPOSE: This study was performed to assess the performance of the dynamic phase subtraction (DPS) map for dynamic contrast-enhanced magnetic resonance imaging (MRI) of the breast. A DPS map is a map image with pixel-by-pixel subtraction of an early-phase image from a delayed-phase image obtained in a dynamic study.
MATERIALS AND METHODS: The use of the DPS map was analyzed retrospectively in 53 patients (32-84 years old) who underwent dynamic contrast-enhanced MRI of the breast. Sensitivity and specificity were compared with and without a DPS map for masses diagnosed as malignant lesions by biopsy. In addition, the patterns of time-intensity curves 30 seconds, 90 seconds, and 5 minutes after injection of contrast agent were compared with and without a DPS map.
RESULTS: Sensitivity increased from 0.78 to 0.95, and specificity increased from 0.71 to 0.95 with reference to the DPS map. The pattern of TIC changed from continuous to a plateau in 9 cases, from a plateau to washout in 21 cases, and from continuous to washout in 7 cases.
CONCLUSION: Use of the DPS map of dynamic contrast-enhanced MRI of the breast results in high detection rates of malignant masses, allows accurate ROI setting of TIC, and reduces operator's task.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082548     DOI: 10.1097/RCT.0b013e318232fc6c

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.

Authors:  Norikazu Koori; Tosiaki Miyati; Naoki Ohno; Hiroko Kawashima; Hiroko Nishikawa
Journal:  J Appl Clin Med Phys       Date:  2022-05-20       Impact factor: 2.243

2.  Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases.

Authors:  Lea Starck; Bente Sandvei Skeie; Gunnar Moen; Renate Grüner
Journal:  Neurooncol Adv       Date:  2022-05-13

3.  Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

Authors:  Benjamin M Ellingson; Hyun J Kim; Davis C Woodworth; Whitney B Pope; Jonathan N Cloughesy; Robert J Harris; Albert Lai; Phioanh L Nghiemphu; Timothy F Cloughesy
Journal:  Radiology       Date:  2013-11-27       Impact factor: 11.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.